peroxynitrous acid has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlt, S; Böger, RH; Eichenlaub, M; Jahn, H; Lehmbeck, JT; Maas, R; Schulze, F; Schwedhelm, E | 1 |
| Bilkei-Gorzo, A; Debeir, T; Dumitrescu-Ozimek, L; Galldiks, N; Heiss, WD; Heneka, MT; Hoehn, M; Jacobs, AH; Klockgether, T; Ramanathan, M; Sastre, M; Staufenbiel, M; Zimmer, A | 1 |
2 other study(ies) available for peroxynitrous acid and Cognition Disorders
| Article | Year |
|---|---|
Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine; Biomarkers; Body Mass Index; Case-Control Studies; Cognition Disorders; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Risk Factors | 2008 |
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Astrocytes; Brain; Cognition Disorders; Female; Locus Coeruleus; Mice; Mice, Transgenic; Microglia; Nerve Degeneration; Nitric Oxide Synthase Type II; Norepinephrine; Peroxynitrous Acid; Plaque, Amyloid; Positron-Emission Tomography; Vesicular Acetylcholine Transport Proteins | 2006 |